In clinical samples of 117 HNSCC patients, we found that 68 (58%) patients were harboring wild-type EGFR, 39 (33%) had the heterozygous genotype, while 10 (9%) were homozygous for EGFR R521K. This evidence concerns the gene EGFR and head and neck squamous cell carcinoma.